| NCT Number | NCT07301463 |
| Lead Sponsor | Abbisko Therapeutics Co, Ltd |
| Conditions | Achondroplasia |
| Enrollment | 260 participants |
| Start Date | 2025-06-20 |
| Primary Completion | 2028-12-30 (estimated) |
| Study Completion | 2039-04-30 (estimated) |
| Updated on ClinicalTrials.gov | 2025-12-24 |